U.S. Food and Drug Administration (FDA)

The U.S. Food and Drug Administration (FDA) is an essential federal agency operating under the Department of Health and Human Services. Based in Silver Spring, Maryland, the FDA plays a crucial role in safeguarding public health by regulating food safety, pharmaceuticals, medical devices, and other products that significantly impact health and wellness.

Financial Indicators

The FDA does not operate like a traditional company with revenue streams. Instead, it functions with a budget allocated by the federal government. For the fiscal year 2023, the FDA's budget stands at approximately $6.4 billion. This funding is crucial for supporting the agency's comprehensive regulatory activities and innovative initiatives, such as the integration of AI technologies.

Significant Events

A notable achievement for the FDA was the successful completion of its first AI-assisted scientific review pilot program. This initiative is part of the FDA's broader strategy to adopt technological advancements to enhance the efficiency of its regulatory processes. The AI pilot program is designed to streamline scientific reviews, reducing the time required to bring innovations to market while ensuring safety and efficacy standards are upheld.

Future Plans

Building on the success of the AI pilot, the FDA plans to expand the deployment of AI technology across all its centers by June 2025. This strategic expansion is expected to improve consistency, reduce human error, and enhance overall efficiency in regulatory affairs. Furthermore, the FDA has proposed a Healthy Labeling Rule to establish front-of-package rating labels for saturated fat, sodium, and added sugar, with public comments invited until July 15, 2025.

Additionally, the FDA has set a 60-day aging requirement for raw milk cheeses, a regulation that has been questioned by recent research findings.

Modified: 2025/11/01

---